UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 44

Sortiert nach

Small Dense Low-Density Lipoprotein Cholesterol Predicts Atherosclerotic Cardiovascular Disease in the Copenhagen General Population Study

Journal of the American College of Cardiology, 2020-06, Vol.75 (22), p.2873-2875

2020

Volltextzugriff (PDF)

A third of nonfasting plasma cholesterol is in remnant lipoproteins: Lipoprotein subclass profiling in 9293 individuals

Atherosclerosis, 2019-07, Vol.286, p.97-104

2019

Volltextzugriff (PDF)

Reduced 25-hydroxyvitamin D and risk of Alzheimer’s disease and vascular dementia

Alzheimer's & dementia, 2014-05, Vol.10 (3), p.296-302

2014

Volltextzugriff (PDF)

Lipoprotein(a) and Body Mass Compound the Risk of Calcific Aortic Valve Disease

Journal of the American College of Cardiology, 2022-02, Vol.79 (6), p.545-558

2022

Volltextzugriff (PDF)

Evaluation of four laboratory-based high-throughput SARS-CoV-2 automated antigen tests compared to RT-PCR on nasal and oropharyngeal samples

Journal of clinical virology, 2023-07, Vol.164, p.105472-105472, Article 105472

2023

Volltextzugriff (PDF)

Primary Prevention With Statins

Journal of the American College of Cardiology, 2015-12, Vol.66 (24), p.2699-2709

2015

Volltextzugriff (PDF)

Familial hypercholesterolaemia - secular trends in age at death and coronary heart disease

Atherosclerosis, 2024-08, Vol.395

2024

Volltextzugriff (PDF)

Remnant cholesterol reduction of 2 mmol/L likely reduces absolute 10-year risk of atherosclerotic cardiovascular disease by 6-17% in primary prevention

Atherosclerosis, 2024-08, Vol.395

2024

Volltextzugriff (PDF)

VLDL Cholesterol Accounts for One-Half of the Risk of Myocardial Infarction Associated With apoB-Containing Lipoproteins

Journal of the American College of Cardiology, 2020-12, Vol.76 (23), p.2725-2735

2020

Volltextzugriff (PDF)

High lipoprotein(s) as a cause of chronic kidney disease: A population-based Mendelian randomization study

Atherosclerosis, 2024-08, Vol.395

2024

Volltextzugriff (PDF)

Sex differences of lipoprotein(a) levels and associated risk of morbidity and mortality by age: The Copenhagen General Population Study

Atherosclerosis, 2022-08, Vol.355, p.76-82

2022

Volltextzugriff (PDF)

High body mass index, intermediate metabolic risk factors, and risk of vascular-related dementia: Observational and genetic studies

Atherosclerosis, 2024-08, Vol.395

2024

Volltextzugriff (PDF)

Elevated LDL Triglycerides and Atherosclerotic Risk

Journal of the American College of Cardiology, 2023-01, Vol.81 (2), p.136-152

2023

Volltextzugriff (PDF)

Reply: Peculiar Paradoxical Results That Puzzle Me

Journal of the American College of Cardiology, 2021-04, Vol.77 (13), p.1699-1700

2021

Volltextzugriff (PDF)

Primary Prevention With Statins: ACC/AHA Risk-Based Approach Versus Trial-Based Approaches to Guide Statin Therapy

Journal of the American College of Cardiology, 2015-12, Vol.66 (24), p.2699-2709

2015

Volltextzugriff (PDF)

Reply

Journal of the American College of Cardiology, 2021-04, Vol.77 (13), p.1699-1700

2021

Volltextzugriff (PDF)

Low 25-hydroxyvitamin d, blood pressure, hypertension, and ischemic stroke: a mendelian randomization study of 109662 individuals from the general population

Atherosclerosis, 2017-08, Vol.263, p.e4-e4

2017

Volltextzugriff (PDF)

Elevated plasma apolipoprotein E levels in people living with HIV: Associations with biomarkers and HIV-specific risk factors

Atherosclerosis, 2024-03, Vol.390, p.117457-117457, Article 117457

2024

Volltextzugriff (PDF)

Elevated lipoprotein(a) in mitral and aortic valve calcification and disease: The Copenhagen General Population Study

Atherosclerosis, 2022-05, Vol.349, p.166-174

2022

Volltextzugriff (PDF)

Potential clinical implications of targeted spirometry for detection of COPD: A contemporary population-based cohort study

Respiratory medicine, 2022-06, Vol.197, p.106852-106852, Article 106852

2022

Volltextzugriff (PDF)

Prognosis of COPD depends on severity of exacerbation history: A population-based analysis

Respiratory medicine, 2019-08, Vol.155, p.141-147

2019

Volltextzugriff (PDF)

Reply

Journal of the American College of Cardiology, 2016-04, Vol.67 (16), p.1974-1975

2016

Volltextzugriff (PDF)

Plasma immunoglobulin E and risk of exacerbation and mortality in chronic obstructive pulmonary disease: A contemporary population-based cohort

Annals of allergy, asthma, & immunology, 2022-10, Vol.129 (4), p.490-496

2022

Volltextzugriff (PDF)

Lung-function trajectories: relevance and implementation in clinical practice

The Lancet (British edition), 2024-04, Vol.403 (10435), p.1494-1503

2024

Volltextzugriff (PDF)

Reply to: “Methodological issues regarding: “A third of nonfasting plasma cholesterol is in remnant lipoproteins: Lipoprotein subclass profiling in 9293 individuals””

Atherosclerosis, 2020-06, Vol.302, p.57-58

2020

Volltextzugriff (PDF)

1 – 25 von 44

Suche als RSS-Feed

Aktive Filter

KollektionElsevier ScienceDirect Journals Complete

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(44)
Mit Volltextzugriff
(44)

Publikationsform

Artikel
(44)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Small Dense Low-Density Lipoprotein Cholesterol Predicts Atherosclerotic Cardiovascular Disease in the Copenhagen General Population Study

A third of nonfasting plasma cholesterol is in remnant lipoproteins: Lipoprotein subclass profiling in 9293 individuals

Reduced 25-hydroxyvitamin D and risk of Alzheimer’s disease and vascular dementia

Lipoprotein(a) and Body Mass Compound the Risk of Calcific Aortic Valve Disease

Evaluation of four laboratory-based high-throughput SARS-CoV-2 automated antigen tests compared to RT-PCR on nasal and oropharyngeal samples

Primary Prevention With Statins

Familial hypercholesterolaemia - secular trends in age at death and coronary heart disease

Remnant cholesterol reduction of 2 mmol/L likely reduces absolute 10-year risk of atherosclerotic cardiovascular disease by 6-17% in primary prevention

VLDL Cholesterol Accounts for One-Half of the Risk of Myocardial Infarction Associated With apoB-Containing Lipoproteins

High lipoprotein(s) as a cause of chronic kidney disease: A population-based Mendelian randomization study

Sex differences of lipoprotein(a) levels and associated risk of morbidity and mortality by age: The Copenhagen General Population Study

High body mass index, intermediate metabolic risk factors, and risk of vascular-related dementia: Observational and genetic studies

Elevated LDL Triglycerides and Atherosclerotic Risk

Reply: Peculiar Paradoxical Results That Puzzle Me

Primary Prevention With Statins: ACC/AHA Risk-Based Approach Versus Trial-Based Approaches to Guide Statin Therapy

Reply

Low 25-hydroxyvitamin d, blood pressure, hypertension, and ischemic stroke: a mendelian randomization study of 109662 individuals from the general population

Elevated plasma apolipoprotein E levels in people living with HIV: Associations with biomarkers and HIV-specific risk factors

Elevated lipoprotein(a) in mitral and aortic valve calcification and disease: The Copenhagen General Population Study

Potential clinical implications of targeted spirometry for detection of COPD: A contemporary population-based cohort study

Prognosis of COPD depends on severity of exacerbation history: A population-based analysis

Reply

Plasma immunoglobulin E and risk of exacerbation and mortality in chronic obstructive pulmonary disease: A contemporary population-based cohort

Lung-function trajectories: relevance and implementation in clinical practice

Reply to: “Methodological issues regarding: “A third of nonfasting plasma cholesterol is in remnant lipoproteins: Lipoprotein subclass profiling in 9293 individuals””

Aktive Filter

Suchergebnisse filtern